Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

Factor Bioscience to Deliver Seven Presentations at the American Society of Gene & Cell Therapy

Factor Bioscience Inc., a Cambridge-based biotechnology company focused on developing mRNA and cell-engineering technologies, announced its participation in the American Society of Gene & Cell Therapy. Factor will deliver seven presentations,...

ImmunityBio Announces FDA Approval of ANKTIVA®,

the potential to change the way we treat bladder cancer.” About ImmunityBio: ImmunityBio is a vertically-integrated biotechnology company developing next-generation therapies and vaccines that bolster the natural immune system to defeat cancers and...

Scientific article highlights Namodenoson as promising for advanced liver cancer and MASH

Can-Fite BioPharma Ltd. a biotechnology company advancing a pipeline of proprietary small molecule drugs that address oncological and inflammatory diseases, announced that Biomedicines published an article titled “Namodenoson at the Crossroad of...

Nested Therapeutics Receives FDA Clearance for IND Application of NST-628, a Groundbreaking Pan-RAF/MEK Molecular Glue

Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) cleared the investigational new drug (IND)....

CorDx Receives Emergency Use Authorization

Multiplex Rapid Test, or to inquire about distribution opportunities, visit CorDx.com. About CorDx: CorDx, a global biotechnology organization, is transforming the global diagnostics industry with innovative R&D solutions, a vertically integrated...

Psilera Welcomes Biopharma Executive Dr. Magali Haas to its Board of Directors

Psilera, a leading biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders, is pleased to announce the appointment of Magali Haas, M.D., Ph.D., to its esteemed Board of Directors. Dr. Haas brings a wealth...

Gedeon Richter Chooses Trial Interactive for Streamlined Clinical Trial Management

eClinical platform was designed by clinical professionals for clinical professionals. It is used by pharmaceutical, biotechnology, medical device, and CRO companies to streamline product development lifecycles in a secure, 21 CFR Part 11-compliant...

Sapience Therapeutics to Present Multiple Posters at the American Association for Cancer Research

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, announced three poster presentations at the 2024...

Ginkgo Technology Network Launches, Providing an Integrated R&D

Ginkgo has acquired over a dozen companies and has deep strategic partnerships with many others in the broader biotechnology ecosystem. As such, Ginkgo is uniquely experienced as a systems integrator, offering customers a robust set of services...

HemoSonics' Quantra® Hemostasis System

Cartridges has been named a finalist in the 2024 Edison™ Awards. The company was honored in the health, medical, and biotechnology category for its Quantra Hemostasis System. The Quantra System with QPlus and QStat Cartridges provides comprehensive...

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation

microbiome health, gut-brain health, and healthy metabolism. From discovery to scale, the company applies science, biotechnology, and intentional development to deliver probiotics, postbiotics, and synbiotics for the business-to-business functional...

Trailblazing 3D human liver models yield accurate MASH phenotype

models to impact drug development at every stage. About Viscient Biosciences: Viscient Biosciences is an early-stage biotechnology company that is developing novel therapies for MASH and other liver diseases. Its lead compound, built to a novel...

About Us | Pharmaceutical-Era.com - Leading B2B Media for the Pharmaceutical Industry

innovation, and collaboration. Explore Pharmaceutical Era today and unlock a world of possibilities in the realm of biotechnology and pharmaceuticals. For media inquiries, partnership opportunities, or general inquiries, please contact us at...

Results 81 - 93 of 93